Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label, Single-group, Long-term Follow-up Trial of Lu AG22515 in Patients With Moderate-to-severe Thyroid Eye Disease

NCT06557850 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT06557850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06557850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label, Single-group, Long-term Follow-up Trial of Lu AG22515 in Patients With Moderate-to-severe Thyroid Eye Disease
Lead sponsor
H. Lundbeck A/S
Phase
Phase 1
Overall status
Active, not recruiting
Start date
September 19, 2024
Completion date
September 29, 2026
Enrollment
20 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid eye disease